Nephrogenic metabolic acidosis;Nefrogénna metabolická acidóza

Vnitrni Lekarstvi

Volumn 49, Issue 5, 2003, Pages 370-373

  Dzúrik, Rastislav ^a   Spustova V ^a  

^a INST OF PREV AND CLINICAL MEDICINE   (Slovakia)

Author keywords

Glutamine; Glutamine Synthesis; Metabolic acidosis; Phosphate dependent glutaminase; Phosphate independent glutaminase

Indexed keywords

ALBUMIN; AMINO ACID; AMMONIA; GLUTAMINASE; PARATHYROID HORMONE;

ARTICLE; DISEASE COURSE; ENZYME LOCALIZATION; FANCONI RENOTUBULAR SYNDROME; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERPHOSPHATEMIA; INSULIN RESISTANCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; METABOLIC ACIDOSIS; MICROVILLUS; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS INHIBITION; RENAL OSTEODYSTROPHY; RISK FACTOR; URINARY EXCRETION;

ACIDOSIS, RENAL TUBULAR; GLUTAMINE; HUMANS; KIDNEY;

EID: 0038463932     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Brunskill, N., Klahr, S.: Mechanisms of progressive renal failure. In: El Nahas, A. M., Mallick, N. P., Anderson, S.: Prevention of progressive renal failure. Oxford: Oxford Med. Publ., 1993, 1-61
2. Castell, L. M., Bevan, S. J., Calder, P. et al.: The role of glutamine in the immune system and intestinal function in catabolic states. Amino acids. 1994, 231-243
3. Dzúrik, R.: Uraemia. 1. vyd. Bratislava: Vydavatel'stvo SAV, 1973, 145 s.
4. Dzúrik, R.: Metabolic alterations caused by uraemia. Proc. EDTA, 17, 1980, 577-585
5. Dzúrik, R., Spustová, V., Krivošíková, Z. et al.: Hippurate participates in the correction of metabolic acidosis. Kidney Int., 59 (Suppl. 78), 2001, S278-S281
6. Fedelešová, V., Slugeňová, E., Dzúrik, R.: Porucha acidifikačnej schopnosti obličiek u chorých s intersticiálnou nefritídou. Vnitř. Lék., 33, 1987, 436-442.
7. Guder, W. G.: Renal and hepatic nitrogen metabolism in systemic acid base regulation. J. Clin. Chem. Biochem., 25, 1987, 457-466
8. Hörl, W.H.: Genesis of uraemic syndrome. In: Davison, J. et al. (Eds.): Oxford textbook of clinical nephrology. Oxford: Oxford Med. Publ., 1998, 1821-1836
9. Krivošíková, Z., Dušinská, M., Spustová, V. et al.: DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan. Kidney Int., 59 (Suppl. 78), 2001, S212-S215
10. Mályusz, M., Hackl, A., Wrigge, P.: Ammonia production from hippurate by the rat kidney in vitro. Renal Physiol., 17, 1994, 307-315
11. May, R. C., Bailey, J. L., Mitch, W. E. et al.: Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int., 49, 1996, 679-683
12. McSherry, E.: Acidosis and growth in nonuremic renal disease. Kidney Int., 14, 1978, 349-354
13. Mitch, W. E.: Uremic acidosis and protein metabolism. Curr. Opin. Nephrol. Hypert., 4, 1995, 488-492
14. Rasic-Milutinovic, Z., Perunicic-Pekovic, G., Pljesa, S.: Clinical significance of pathogenic mechanisms of insulin resistance in chronic renal insufficiency. 3. pathogenic factors of insulin resistance in chronic renal insufficiency. Med. Pregl., 53, 2000, 159-163
15. Renal Ass. Royal Coll. Physiacians: Treatment of adult patients with renal failure. Recommended standards and audit measures. Royal Coll. Physicians London, 2nd Ed. 1997
16. Spustová, V., Krivošiková, Y., Gavulová, L. et al.: Nephrogenic metabolic acidosis. Klin. Bioch. Metab., 5, 1997, 170-175
17. Spustová, V., Dzúrik, R.: The mechanism of hippurate inhibition of glucose utilization in rat diaphragm. Biochem. Clin. Bohemoslov., 20, 1991, 21-25
18. Spustová, V., Dzúrik, R.: Renálna insuficiencia. Martin: Osveta, 1992, 149 s.